| Literature DB >> 30344808 |
Arjun R Sondhi1,2, Jacob E Kurlander1,3,2, Stacy B Menees1,3, Sameer D Saini1,4.
Abstract
BACKGROUND: This systematic review aims to assess the accuracy of hydrogen breath testing as a predictor of bowel preparation.Entities:
Keywords: Bowel preparation; Breath test; Colonoscopy; Hydrogen; Quality
Year: 2018 PMID: 30344808 PMCID: PMC6188035 DOI: 10.14740/gr1078w
Source DB: PubMed Journal: Gastroenterology Res ISSN: 1918-2805
Figure 1Flow chart of studies identified by literature search.
Study Characteristics
| Altomare group A (PEG only) [ | Altomare group B (PEG + inulin) [ | Mann et al (2003) [ | Urita et al (2003) [ | Meyer et al (2001) [ | Meyer et al (2002) [ | |
|---|---|---|---|---|---|---|
| Study setting and design | ||||||
| Country | Italy | USA | Japan | USA | USA | |
| Study design | Prospective | |||||
| Colonoscopy indication | Screening, surveillance and diagnostic | Unstated | Diagnostic | Unstated | Unstated | |
| Patient selection | Non-consecutive | Unstated | Consecutive | Unstated | ||
| Patient blinded? | Unstated | |||||
| Endoscopist blinded? | Yes | Unstated | ||||
| Breath tester blinded? | Yes | Unstated | ||||
| Exclusion of H2 non-producers? | Yes | No | Included, analyzed as subgroup | No | No | |
| Inclusion criteria | Signs/symptoms of distal small intestinal diseases, screening or surveillance for colorectal cancer, follow up evaluation of IBD under medical therapy | Unstated | Diagnostic, non-emergent endoscopy | Unstated | Unstated | |
| Exclusion criteria | History of liver, lung, heart, metabolic or neurological disease; lack of compliance, emergency colonoscopy, antibiotic or motility agent 1 month before endoscopy or recent smoking | Unstated | Renal insufficiency, ascites, heart failure, history of abdominal surgery, treatment prokinetics or antibiotics in 6 weeks before endoscopy | Unstated | Unstated | |
| Breath testing protocol | ||||||
| Baseline (pre-preparation) HBT? If yes, timing | Yes, 5 min before preparation | No | Yes, before starting preparation after fasting | No | Yes, timing unstated | |
| Timing of HBT relative to colonoscopy | 5 min before colonoscopy | Unstated | Every 15 min for 4 h before colonoscopy | Unstated | Unstated | |
| Non-hydrogen gases assessed? | No | |||||
| Substrate used | None | Inulin | None | Lactulose | None | ½ pt received 1,250 mg Fibercon the day before colonoscopy |
| Equipment used | LactoFAN | Bedfont Scientific EC 60 gastrolyzer | TGA-2000, Teramecs | MD-80 breath analyzer | Unstated | |
| Colonoscopy protocol | ||||||
| Timing of colonoscopy | 9 a.m. | Unstated | 1 p.m. | Unstated | ||
| Bowel preparation scale | Excellent/fair/poor | Excellent/fair/poor | Excellent/fair/poor | 1 - 5 (best to worst) | 1 - 5 (best to worst) | |
| Definition of “adequate preparation” | Unstated | Unstated | Excellent/fair considered “adequate” | Adequate=1 - 2, inadequate=3 - 5 | ||
| Pre-colonoscopy dietary changes | 12 h fast before colonoscopy | Clear-liquid diet the day before colonoscopy followed by overnight fast | “Usual diet” the day before procedure, then overnight fast before morning time preparation | Unstated | ||
| Group A: | ||||||
| Purgative used | PEG | PEG | PEG | Unstated | Fleet’s phosphosoda, visicol or golytely | |
| Single versus split dose preparation | Unstated | Single | Single | Unstated | ||
HBT Outcomes by Study
| Altomare group A (PEG only) [ | Altomare group B (PEG + inulin) [ | Mann et al. (2003) [ | Urita et al. (2003) [ | Meyer et al. (2001) [ | Meyer et al. (2002) [ | |
|---|---|---|---|---|---|---|
| HBT outcomes | Patients did HBT once (inpatient and outpatient). H2 level in excellent/fair versus poor was 1.4 ± 0.1 ppm versus 3.5 ± 0.2 ppm (P < 0.001). | Pre-prep to post-prep H2 levels: 23.8 ± 2.9 ppm versus 2.3 ± 0.3 ppm (P < 0.001). | H2 levels were lower in the fair-to-excellent prep group (2.2 ± 0.2 ppm) relative to the poor prep group (14.5 ± 1.5 ppm, P < 0.005) | No difference in baseline H2 levels between the adequate and inadequate group | H2 levels were lower in the adequately prepared group (1.56 ppm) relative to the inadequately prepared group (2.11 ppm, P < 0.05) | No difference between baseline H2 levels and post-prep H2 levels in the adequately prepared group relative to the inadequately prepared group |
Statistical Analysis and Proposed Hydrogen Level Cutoffs for Poor Bowel Preparation
| Altomare group A (PEG only) [ | Altomare group B (PEG + inulin) [ | Mann et al (2003) [ | Urita et al (2003) [ | Meyer et al (2001) [ | Meyer et al (2002) [ | |
|---|---|---|---|---|---|---|
| H2 cutoff value suggested (ppm) | 3 | 3 | 5 | 10 at 90 and 240 min into prep ingestion | Unstated | N/a since no difference was found |
| Sensitivity (%) | 72 | 83 | 96.7 | 100 | ||
| Specificity (%) | 93 | 87 | 87.5 | 100 | ||
| NPV (%) | 93 | 93 | 77.8 | 100 | ||
| PPV (%) | 72 | 69 | 98.3 | 100 | ||
| AUROC/c-statistic | Not available | 0.93 | Not available | Not available |
QUADAS-2 [10] Assessment
| Altomare et al (both studies) [ | Mann et al (2003) [ | Urita et al (2003) [ | Meyer et al (2001) [ | Meyer et al (2002) [ | |
|---|---|---|---|---|---|
| Overall QUADAS-2 rating | Low risk of bias | Medium risk of bias | Low risk of bias | Medium risk of bias | Medium risk of bias |
| Domain 1 (patient selection) | Unclear if selection introduced bias; overall low concern that included patients did not match the review question | Unclear if selection introduced bias; overall low concern that included patients did not match the review question | Low risk of selection introducing bias; overall low concern that included patients did not match the review question | Unclear if selection introduced bias; overall low concern that included patients did not match the review question | Unclear if selection introduced bias; overall low concern that included patients did not match the review question |
| Domain 2 (index test) | Low risk that conduction or interpretation of the index test could have introduced bias; low concern that the index test, its conduct or interpretation differed from the review question | Low risk that conduction or interpretation of the index test could have introduced bias; low concern that the index test, its conduct or interpretation differed from the review question | Low risk that conduction or interpretation of the index test could have introduced bias; low concern that the index test, its conduct or interpretation differed from the review question | Low risk that conduction or interpretation of the index test could have introduced bias; low concern that the index test, its conduct or interpretation differed from the review question | Low risk that conduction or interpretation of the index test could have introduced bias; unclear concern that the index test, its conduct or interpretation differed from the review question |
| Domain 3 (reference standard) | Low risk that the reference standard, its conduct or interpretation could have introduced bias; low concern regarding the target condition matching the review question | Unclear risk that the reference standard, its conduct or interpretation could have introduced bias; low concern regarding the target condition matching the review question | Unclear risk that the reference standard, its conduct or interpretation could have introduced bias; low concern regarding the target condition matching the review question | Unclear risk that the reference standard, its conduct or interpretation could have introduced bias; low concern regarding the target condition matching the review question | Unclear risk that the reference standard, its conduct or interpretation could have introduced bias; low concern regarding the target condition matching the review question |
| Domain 4 (flow and timing) | Low risk that patient flow introduced bias | Unclear risk that patient flow introduced bias | Low risk that patient flow introduced bias | Unclear risk that patient flow introduced bias | Unclear risk that patient flow introduced bias |